Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1821-1830 of 2905 for cancer

Edit search filters
  1. AUTO1 In Relapsed Or Refractory B-ALL

    Rochester, MN

  2. A Study To Evaluate AuTophagy Activation For Cardiomyopathy Due To Anthracycline TReatment

    Rochester, MN

  3. A Study To Evaluate CC-98633 To Treat Subjects With Relapsed And/or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study Of ONC201 For Patients With H3 K27M-mutant And/or Midline High Grade Gliomas

    Jacksonville, FL, Rochester, MN

  5. Trametinib, Combination Chemotherapy, And Radiation Therapy In Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

    Rochester, MN

  6. A Study Comparing Gemcitabine With Or Without AZD 1775 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

  7. A Study To Evaluate T-DM1 With Or Without Abemaciclib In Women And Men With HER2-positive Advanced Or Metastatic Breast Cancer

    Jacksonville, FL, Rochester, MN

  8. Dose Escalation And Double-blind Study Of Veliparib In Combination With Carboplatin And Etoposide In Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  9. A Study Comparing Tarlatamab, Durvalumab, Carboplatin, And Etoposide Versus Durvalumab, Carboplatin, And Etoposide In First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

    Rochester, MN

  10. Dose-Escalated Photon IMRT Or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy And Temozolomide In Treating Patients With Newly Diagnosed Glioblastoma

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer